These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 395095)

  • 21. [Raised glucagon levels of the blood induced by arginine: relation to blood sugar, blood insulin and STH in aged non-diabetics and diabetics].
    Ferrero E; Casale G; Tassi G; Ciaponi A
    Minerva Med; 1978 Apr; 69(18):1233-9. PubMed ID: 662151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a closed-loop artificial pancreas.
    Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L
    Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
    Froesch ER; Blatter G; Morell B
    Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of glycosylated haemoglobin concentration during artificial endocrine pancreas treatment of diabetics. Evidence for a short-term effect on HbA 1 (a+b+c) levels.
    Bolli G; Cartechini MG; Compagnucci P; Santeusanio F; Massi-Benedetti M; Calabrese G; Puxeddu A; Brunetti P
    Diabetologia; 1980; 18(2):125-30. PubMed ID: 6988271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas.
    Drouin P; Rousselle D; Pointel JP; Voisin G; Stoltz JF; Clemens AH; Debry G
    Horm Metab Res Suppl; 1979; (8):107-10. PubMed ID: 395064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Calcitonin on plasma glucose, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetic subjects.
    Sgambato S; Passariello N; Giugliano D; Torella R; D'Onofrio F
    Acta Diabetol Lat; 1981; 18(3):235-41. PubMed ID: 7029989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system).
    Pfeiffer EF; Thum C; Clemens AH
    Horm Metab Res; 1974 Sep; 6(5):339-42. PubMed ID: 4607598
    [No Abstract]   [Full Text] [Related]  

  • 31. Endocrine pancreatic response of children with onset of insulin-requiring diabetes before age 3 and after age 5.
    Ternand C; Go VL; Gerich JE; Haymond MW
    J Pediatr; 1982 Jul; 101(1):36-9. PubMed ID: 7045315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perfect normalization of excessive glucagon responses to intravenous arginine in human diabetes mellitus with the artificial beta-cell.
    Kawamori R; Shichiri M; Kikuchi M; Yamasaki Y; Abe H
    Diabetes; 1980 Sep; 29(9):762-5. PubMed ID: 7002690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of an artificial endocrine pancreas in diabetic pregnancy.
    Tamás G; Bojta J; Báayai Z; Petrányi G; Szalay J
    Horm Metab Res Suppl; 1979; (8):166-8. PubMed ID: 395075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a somatostatin analog on insulin requirement and hormone levels in 6 insulin-dependent juvenile-onset diabetics subjected to artificial pancreas.
    Lenti G; Trovati M; Lorenzati R; Vitelli F; Tagliaferro V; Marocco A; Pagano G
    Acta Diabetol Lat; 1980; 17(1):9-14. PubMed ID: 6106342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of acute hypercalcaemia on arginine induced growth hormone release in diabetic man.
    Kaplan PW; Jung RT
    Horm Metab Res; 1984 Dec; 16 Suppl 1():123-6. PubMed ID: 6532933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon and catecholamine secretion during hypoglycemia in normal and diabetic man.
    Benson JW; Johnson DG; Palmer JP; Werner PL; Ensinck JW
    J Clin Endocrinol Metab; 1977 Mar; 44(3):459-64. PubMed ID: 838846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A portable, Preprogrammable insulin infusion system with 16 rates.
    Kølendorf K; Bojsen J
    Horm Metab Res Suppl; 1979; (8):65-6. PubMed ID: 395092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Artificial endocrine pancreas (author's transl)].
    Kruse-Jarres JD
    J Clin Chem Clin Biochem; 1979 Jul; 17(7):457-63. PubMed ID: 383880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.